Terms: = Thyroid cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Diagnosis
5 results:
1. Cortisol Deficiency in Lenvatinib Treatment of thyroid cancer: An Underestimated Common Adverse Event.
Monti S; Presciuttini F; Deiana MG; Motta C; Mori F; Renzelli V; Stigliano A; Toscano V; Pugliese G; Poggi M
Thyroid; 2022 Jan; 32(1):46-53. PubMed ID: 34663079
[No Abstract] [Full Text] [Related]
2. [IgG4-related disease: about 3 cases].
Abid H; Alaoui MEHHBE; Lamrani MYA; Figuigui M; Ahmed BC; Lahmidani N; Yousfi ME; Benajah DA; Maaroufi M; Abkari ME; Ibrahimi SA; Aqodad N
Pan Afr Med J; 2020; 36():364. PubMed ID: 33235641
[TBL] [Abstract] [Full Text] [Related]
3. Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate Therapy.
Colombo C; De Leo S; Di Stefano M; Vannucchi G; Persani L; Fugazzola L
J Clin Endocrinol Metab; 2019 Mar; 104(3):779-784. PubMed ID: 30383218
[TBL] [Abstract] [Full Text] [Related]
4. High expression of the urokinase plasminogen activator and its cognate receptor associates with advanced stages and reduced disease-free interval in papillary thyroid carcinoma.
Ulisse S; Baldini E; Sorrenti S; Barollo S; Gnessi L; Catania A; Pellizzo MR; Nardi F; Mian C; De Antoni E; D'Armiento M; Frati L
J Clin Endocrinol Metab; 2011 Feb; 96(2):504-8. PubMed ID: 21106716
[TBL] [Abstract] [Full Text] [Related]
5. [Biomarkers in breast cancer].
Kurebayashi J
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1021-6. PubMed ID: 15272579
[TBL] [Abstract] [Full Text] [Related]
